Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Osteosarcoma 29Dendritic Cell Sarcoma, Interdigitating 25Lymphoma 20Burkitt Lymphoma 20Lymphoma, Large B-Cell, Diffuse 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Non-Hodgkin 16Leukemia 16Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Follicular 14Sarcoma 13Recurrence 13Multiple Myeloma 13Leukemia, Myeloid, Acute 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 12Lymphoma, B-Cell, Marginal Zone 12Hodgkin Disease 12Neoplasms, Plasma Cell 11Myelodysplastic Syndromes 11Leukemia, Myeloid, Accelerated Phase 11Myeloproliferative Disorders 10Leukemia, Myelomonocytic, Chronic 10Congenital Abnormalities 10Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic-Phase 9Blast Crisis 9Sezary Syndrome 8Primary Myelofibrosis 8Mycosis Fungoides 8

Interventions

Doxorubicin 4Dexrazoxane 3Methotrexate 2Cisplatin 2pegfilgrastim 1Vincristine 1Rituximab 1Razoxane 1Prednisolone 1Neoadjuvant Therapy 1Leucovorin 1Lenalidomide 1Ifosfamide 1Filgrastim 1Etoposide 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cardiotoxicity × Methotrexate × Sarcoma × Clear all
NCT00019864 2015-06-08

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

National Cancer Institute (NCI)

Phase 2 Terminated
100 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Cardiotoxicity

NCT00003937 2014-08-05

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Children's Oncology Group

Phase 3 Completed
253 enrolled
Sarcoma

Sarcoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡